Satsuma Pharmaceuticals, Inc. - Common stock (NQ:STSA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Satsuma Pharmaceuticals, Inc. - Common stock

< Previous 1 2 3 Next >

Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

June 09, 2023

The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA

May 10, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

April 21, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 ↗

April 18, 2023

Via Benzinga

Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results ↗

April 17, 2023

U.S. stocks traded slightly lower toward the end of trading. The Dow traded down 0.07% to 33,862.05 while the NASDAQ fell 0.24% to 12,093.82. The S&P 500, also fell, dropping, 0.17% to 4,130.78.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 17, 2023

Via Benzinga

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

Gold Drops Below $2,000; Charles Schwab Earnings Top Views ↗

April 17, 2023

U.S. stocks traded mostly flat midway through trading, following the release of economic data. The Dow traded up 0.01% to 33,890.03 while the NASDAQ fell 0.18% to 12,101.34. The S&P 500, also fell,...

Via Benzinga

STSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Satsuma Pharmaceuticals, Inc. Is Fair to Shareholders

April 17, 2023

From Halper Sadeh LLC

Via Business Wire

Why Is SAI.TECH Global (SAI) Stock Down 32% Today? ↗

April 17, 2023

SAI.TECH Global (SAI) stock is down on Monday despite a lack of news concerning the Bitcoin (BTC-USD) mining and clean energy company.

Via InvestorPlace

Why Is Marpai (MRAI) Stock Down 40% Today? ↗

April 17, 2023

Marpai (MRAI) stock is taking a beating on Monday after the company announced a proposed public offering for its shares.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 17, 2023

Via Benzinga

Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today? ↗

April 17, 2023

Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).

Via InvestorPlace

Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket ↗

April 17, 2023

Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.

Via Benzinga

Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today? ↗

April 17, 2023

Satsuma Pharmaceuticals (STSA) stock is taking off on Monday after revealing an acquisition deal with Shin Nippon Biomedical Laboratories.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 17, 2023

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 07, 2023

Via Benzinga

Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 17, 2023

Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 26, 2022

Via Benzinga

Despite Trial Failure, Satsuma Pharma Says Its Migraine Candidate Has Potential For Approval ↗

December 20, 2022

Satsuma Pharmaceuticals Inc (NASDAQ: STSA) provided an update on its STS101 development program and corporate update.

Via Benzinga

Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session ↗

November 17, 2022

Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 17, 2022

Via Benzinga

Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket ↗

November 17, 2022

Gainers

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Satsuma Pharmaceuticals: Here's What You Need To Know ↗

November 15, 2022

Via Benzinga

Expert Ratings for Satsuma Pharmaceuticals ↗

November 15, 2022

Over the past 3 months, 6 analysts have published their opinion on Satsuma Pharmaceuticals (NASDAQ:STSA) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Dow Surges 150 Points; Crude Oil Falls Sharply ↗

November 14, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 14, 2022

Monday saw 33 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 14, 2022

Gainers

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.